Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8,11,14 Eicosatrienoic Acid
2. 8,11,14-eicosatrienoic Acid
3. Dihomo Gamma Linolenic Acid
4. Dihomogammalinolenic Acid
5. Homo Gamma Linolenic Acid
6. Homo-gamma Linolenic Acid
7. Linolenic Acid, Homo-gamma
8. Ro 12 1989
9. Ro 12-1989
10. Ro 121989
1. 1783-84-2
2. Dgla
3. 8,11,14-eicosatrienoic Acid
4. Gamma-homolinolenic Acid
5. Homo-gamma-linolenic Acid
6. Cis-8,11,14-eicosatrienoic Acid
7. Diroleuton
8. (8z,11z,14z)-icosa-8,11,14-trienoic Acid
9. All-cis-8,11,14-eicosatrienoic Acid
10. Bishomo-gamma-linolenic Acid
11. 8z,11z,14z-eicosatrienoic Acid
12. (z,z,z)-8,11,14-eicosatrienoic Acid
13. Ro 12-1989
14. (8z,11z,14z)-icosatrienoic Acid
15. 8,11,14-icosatrienoate
16. 8,11,14-eicosatrienoate
17. (z,z,z)-8,11,14-icosatrienoate
18. Daleuton
19. (z,z,z)-8,11,14-icosatrienoic Acid
20. Cis,cis,cis-8,11,14-eicosatrienoic Acid
21. .gamma.-homolinolenic Acid
22. (z,z,z)-8,11,14-eicosatrienoate
23. 8,11,14-all-cis-eicosatrienoic Acid
24. Dihomo-.gamma.-linolenic Acid
25. All Cis-8,11,14-eicosatrienoic Acid
26. All-cis-icosa-8,11,14-trienoic Acid
27. Ccris 7669
28. 8,11,14-eicosatrienoic Acid, (8z,11z,14z)-
29. (z,z,z)-icosatri-8,11,14-enoic Acid
30. Cis-8,cis-11,cis-14-eicosatrienoic Acid
31. Dihomo-gamma-linolenate
32. 8c,11c,14c-eicosatrienoic Acid
33. 8, 11, 14-eicosatrienoic Acid
34. Ds107
35. Eicosa-8z,11z,14z-trienoic Acid
36. Dihomo-
37. A-linolenic Acid
38. 20:3, N-6,9,12 All-cis
39. All-cis-8,11,14-icosatrienoic Acid
40. Bishomo-.gamma.-linolenic Acid
41. Chembl465183
42. Ds107g
43. Fc398rk06s
44. 8,11-14-eicosatrienoic Acid, (z,z,z)-
45. Chebi:53486
46. Ds-107
47. Ds-107g
48. 20:3 (.omega.-6) Fatty Acid
49. C20:3, N-6,9,12 All-cis
50. All-cis-eicosa-8,11,14-trienoic Acid
51. C20:3n-6,9,12
52. Fa(20:3(8z,11z,14z))
53. 20:3(n-6)
54. All-cis-8,11,14-eicosatrienoate
55. Homo-gamma-linolensaeure
56. 8,11,14-icosatrienoic Acid
57. Unii-fc398rk06s
58. Eicosatrienoate
59. Dihomolinolenate
60. Bml3-b11
61. 8c,11c,14c-eicosatriensaeure
62. Gamma-homolinolenate
63. Einecs 217-233-0
64. Mfcd00065721
65. All-cis-eicosa-8,11,14-triensaeure
66. Homo-gamma-linolenate
67. C 20:3 N-6
68. Bishomo-gamma-linolenate
69. Dihomo-y-linolenic Acid
70. Daleuton [inn]
71. Dihomo-gamma-linolenic-acid
72. Dibromo-gamma-linolenic Acid
73. Di-homo Gamma-linolenic Acid
74. Dihomo -gamma-linolenic Acid
75. Diroleuton [who-dd]
76. Bspbio_001286
77. Schembl842729
78. 8z,11z,14z-eicosatrienoate
79. Cis-8,11,14-eicosatrienoate
80. Gtpl9775
81. Dtxsid00912351
82. Hms1361a08
83. Hms1791a08
84. Hms1989a08
85. Hms3402a08
86. Hms3649h11
87. 8,11,14-all-cis-eicosatrienoate
88. Hy-a0143
89. Zinc4521470
90. Bdbm50269534
91. Lmfa01030158
92. All Cis-8,11,14-icosatrienoic Acid
93. (z,z,z)-icosatri-8,11,14-enoate
94. Cis,cis,cis-8,11,14-eicosatrienoate
95. Cis-8,cis-11,cis-14-eicosatrienoate
96. Db00154
97. Idi1_033756
98. Ncgc00161350-01
99. Ncgc00161350-02
100. Ncgc00161350-03
101. As-65384
102. 20:3n-6
103. Cis-8,11,14-eicosatrienoic Acid, >=99%
104. Cs-0017463
105. E0640
106. C03242
107. Dihomo- Gamma -linolenic Acid (20:3, N-6)
108. (8z,11z,14z)-8,11,14-eicosatrienoic Acid
109. Q415398
110. Sr-01000946659
111. 8,11,14-eicosatrienoic Acid, (z,z,z)- (8ci)
112. Sr-01000946659-1
113. Brd-k20152659-001-02-0
114. Cis-8,11,14-eicosatrienoic Acid, Analytical Standard
115. 8,11,14-eicosatrienoic Acid, (8z,11z,14z)- (9ci)
| Molecular Weight | 306.5 g/mol |
|---|---|
| Molecular Formula | C20H34O2 |
| XLogP3 | 7.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 15 |
| Exact Mass | 306.255880323 g/mol |
| Monoisotopic Mass | 306.255880323 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 327 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 3 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For nutritional supplementation, also for treating dietary shortage or imbalance
Treatment of atopic dermatitis
Dihomo gamma-linolenic acid or DHLA is an n-6 (omega-6) polyunsaturated fatty acid. It is comprised of 20 carbon atoms and three double bonds. DHLA is a byproduct of the 18 carbon gamma-linolenic acid (GLA). DHLA is then converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect.
DHLA (or DGLA) is a precursor in the synthesis of prostaglandin E1 (PGE1) as well as the series-3 prostaglandins. It also serves as a precursor in the synthesis of eicosapentaenoic acid (EPA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-thrombogenic, anti-inflammatory and anti-atherogenic properties. PGE1 inhibits platelet aggregation and has a vasodilation action. DHLA has also been shown to reduce the production/activity of tumor necrosis factor alpha.
Digital Content 
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Dihomo-Gamma-Linolenate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihomo-Gamma-Linolenate, including repackagers and relabelers. The FDA regulates Dihomo-Gamma-Linolenate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihomo-Gamma-Linolenate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihomo-Gamma-Linolenate supplier is an individual or a company that provides Dihomo-Gamma-Linolenate active pharmaceutical ingredient (API) or Dihomo-Gamma-Linolenate finished formulations upon request. The Dihomo-Gamma-Linolenate suppliers may include Dihomo-Gamma-Linolenate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihomo-Gamma-Linolenate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihomo-Gamma-Linolenate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dihomo-Gamma-Linolenate active pharmaceutical ingredient (API) in detail. Different forms of Dihomo-Gamma-Linolenate DMFs exist exist since differing nations have different regulations, such as Dihomo-Gamma-Linolenate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dihomo-Gamma-Linolenate DMF submitted to regulatory agencies in the US is known as a USDMF. Dihomo-Gamma-Linolenate USDMF includes data on Dihomo-Gamma-Linolenate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dihomo-Gamma-Linolenate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dihomo-Gamma-Linolenate suppliers with USDMF on PharmaCompass.
Dihomo-Gamma-Linolenate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihomo-Gamma-Linolenate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihomo-Gamma-Linolenate GMP manufacturer or Dihomo-Gamma-Linolenate GMP API supplier for your needs.
A Dihomo-Gamma-Linolenate CoA (Certificate of Analysis) is a formal document that attests to Dihomo-Gamma-Linolenate's compliance with Dihomo-Gamma-Linolenate specifications and serves as a tool for batch-level quality control.
Dihomo-Gamma-Linolenate CoA mostly includes findings from lab analyses of a specific batch. For each Dihomo-Gamma-Linolenate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihomo-Gamma-Linolenate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihomo-Gamma-Linolenate EP), Dihomo-Gamma-Linolenate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihomo-Gamma-Linolenate USP).
LOOKING FOR A SUPPLIER?
